Clinical Trials Browser

Phase 2 × OTHER × entecavir × Clear all

NCT02777814 2019-01-22

Prophylactic or Preemptive Entecavir in Patients With Colorectal Cancer Who Are Inactive Hepatitis B Carriers

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT01914744 2013-08-02

Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL

Phase 2 Unknown

Lymphoma, Non-Hodgkin